Third Wave Files to Raise up to $100M in Potential Stock Offerings | GenomeWeb
NEW YORK (GenomeWeb News) – Third Wave Technologies said yesterday that it has field a shelf registration with the US Securities and Exchange Commission allowing it to sell up to $100 million in securities.
 
The molecular diagnostics company said it may sell an undetermined number of debt securities or common stock, which includes the rights to purchase preferred stock, and that all of these may be issued by exercising warrants.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.